Laura A. Skerlos

Expeditious identification and quantification of mycobacteria species in metalworking fluids using peptide nucleic acid probes

S. Skerlos, Laura A. Skerlos, C. A. Aguilar, 2003 .

In Vitro and In Vivo Activities of PD 0305970 and PD 0326448, New Bacterial Gyrase/Topoisomerase Inhibitors with Potent Antibacterial Activities versus Multidrug-Resistant Gram-Positive and Fastidious Organism Groups

S. Gracheck, M. Huband, E. Ellsworth, 2007, Antimicrobial Agents and Chemotherapy.

Pharmacodynamics of early, high-dose linezolid against vancomycin-resistant enterococci with elevated MICs and pre-existing genetic mutations.

Laura A. Skerlos, D. Hanna, J. Bulitta, 2012, The Journal of antimicrobial chemotherapy.

A class of selective antibacterials derived from a protein kinase inhibitor pharmacophore

Alla Karnovsky, J Richard Miller, V Hayden Thomas, 2009, Proceedings of the National Academy of Sciences.

Antibacterial oxazolidinones possessing a novel C-5 side chain. (5R)-trans-3-[3-Fluoro-4- (1-oxotetrahydrothiopyran-4-yl)phenyl]-2- oxooxazolidine-5-carboxylic acid amide (PF-00422602), a new lead compound.

J. Brieland, Ji-Young Kim, M. Huband, 2007, Journal of medicinal chemistry.